Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Capital Senior Living	Delta 9 Cannabis	Axovant Gene Therapies	MaxCyte	Applied Genetic Technologies
Symbol	NYSE:CSU	CVE:NINE	NASDAQ:AXGT	LON:MXCT	NASDAQ:AGTC
Price Information
Current Price	$0.61	N/A	$2.65	GBX 125	$3.34
52 Week Range	Hold	N/A	Buy	N/A	Buy
Analyst Ratings
Consensus Recommendation	Hold	N/A	Buy	N/A	Buy
Consensus Price Target	$3.15	C$2.20	$18.50	N/A	$16.50
% Upside from Price Target	413.03% upside	∞ upside	598.11% upside	N/A	394.01% upside
Trade Information
Market Cap	$14.39 million	C$89.36 million	$91.69 million	£71.74 million	$60.86 million
Beta	1.78	N/A	1.26	N/A	2.91
Average Volume	253,039	117,300	180,579	1,951	267,479
Sales & Book Value
Annual Revenue	$447.10 million	C$12.87 million	N/A	£18.11 million	$41.69 million
Price / Sales	0.04	0.00	N/A	3.96	1.46
Cashflow	$0.89 per share	N/A	N/A	GBX 23.13 per share	N/A
Price / Cash	0.69	11.91	N/A	5.40	N/A
Book Value	$0.46 per share	C$0.53 per share	$2.47 per share	GBX 28 per share	$4.33 per share
Price / Book	1.33	0.00	N/A	0.04	0.77
Profitability
Net Income	$-36,030,000.00	N/A	$-129,070,000.00	N/A	$-2,010,000.00
EPS	($1.48)	C$0.05	($8.02)	GBX (25.40)	($0.11)
Trailing P/E Ratio	N/A	19.07	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	∞	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-8.06%	N/A	N/A	N/A	N/A
Return on Equity (ROE)	-240.37%	N/A	-241.62%	N/A	-26.07%
Return on Assets (ROA)	-3.43%	N/A	-75.95%	N/A	-21.36%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	78.19%	33.00%	1.28%	1.98%	0.08%
Current Ratio	0.49%	4.44%	1.09%	2.64%	4.33%
Quick Ratio	0.49%	2.04%	1.09%	2.11%	4.33%
Ownership Information
Institutional Ownership Percentage	63.35%	N/A	7.17%	N/A	45.78%
Insider Ownership Percentage	18.60%	N/A	5.50%	N/A	3.10%
Miscellaneous
Employees	6,600	79	45	N/A	78
Shares Outstanding	31.46 million	86.76 million	36.82 million	57.39 million	18.22 million
Next Earnings Date	5/14/2020 (Estimated)	N/A	6/9/2020 (Estimated)	N/A	5/5/2020 (Estimated)
Optionable	Optionable	Optionable	Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources